Full Text View
Tabular View
No Study Results Posted
Related Studies
Treating Alcohol Withdrawal With Oral Baclofen
This study has been completed.
Study NCT00597701   Information provided by St. Mary's Duluth Clinic Health System
First Received: January 9, 2008   Last Updated: February 28, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Alcohol Withdrawal Delirium
Additional conditions recognized in this trial
Delirium
More general conditions related to this trial
Alcohol-Induced Disorders
Alcohol-Induced Disorders, Nervous System
Alcohol-Related Disorders
Confusion
Delirium, Dementia, Amnestic, Cognitive Disorders
Disorders of Environmental Origin
Mental Disorders
Nervous System Diseases
Neurobehavioral Manifestations
Neurologic Manifestations
Neurotoxicity Syndromes
Poisoning
Signs and Symptoms
Substance Withdrawal Syndrome
Substance-Related Disorders
Interventions listed in this trial
Baclofen
placebo
More general drug interventions related to this trial
Central Nervous System Agents
GABA Agents
GABA Agonists
Molecular Mechanisms of Pharmacological Action
Muscle Relaxants, Central
Neuromuscular Agents
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
St. Mary's Duluth Clinic Health System


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services